ArticleJournal of pharmacy & bioallied sciences2025
Evaluation of Potential Drug-Drug Interactions with Antimicrobials among Critically Ill Patients in Intensive Care Units of a Tertiary Care Hospital: A Cross-Sectional Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Critically ill patients in intensive care units (ICUs) are often prescribed multiple drugs, including antimicrobials, increasing the risk of drug-drug interactions (DDIs). This study evaluated the frequency, mechanisms, and severity of potential DDIs with antimicrobials in such patients. Methods: A cross-sectional study was conducted among 292 critically ill patients in the ICU of M S Ramaiah Hospitals from December 2018 to June 2020. Patient data, including demographics and prescribed drugs, were collected. DDIs were analyzed using Micromedex Drug Interaction Checker and classified by mechanism and severity. Results: Of the 292 patients, 35.3% experienced DDIs involving antimicrobials. A total of 220 DDIs were identified, primarily pharmacodynamic (82.73%) and major in severity (68.63%). The occurrence of DDIs correlated significantly with the number of drugs prescribed (r = 0.26, Conclusion: The findings highlight the need for careful drug monitoring and dose adjustments to minimize antimicrobial-related DDIs in critically ill patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.